1. 833 076 ADRs reported to FDA in 2014

   News item 10 October 2015 Pages: 1 - 1

2. Avycaz dose confusion

   News item 10 October 2015 Pages: 2 - 2

3. Becton-Dickinson disposable syringes may reduce potency

   News item 10 October 2015 Pages: 3 - 3

4. Etanercept not linked to schizophrenia-like symptoms

   News item 10 October 2015 Pages: 4 - 4

5. Hepatotoxicity with Ketoconazole HRA for Cushing’s syndrome

   Correspondence 10 October 2015 Pages: 5 - 5

6. Japan's PMDA revises precautions for various products

   News item 10 October 2015 Pages: 6 - 6

7. New contraindication for various PDE5 inhibitors in Canada

   News item 10 October 2015 Pages: 7 - 7

8. Product update in Canada for Malarone drug interaction

   News item 10 October 2015 Pages: 8 - 8

9. Sodium valproate associated with congenital abnormalities

   News item 10 October 2015 Pages: 9 - 9

10. Genetic polymorphism affects MTX discontinuation for RA

    Epidemiology clinical study 10 October 2015 Pages: 10 - 10

11. Switch to anidulafungin improves liver function

    Clinical study 10 October 2015 Pages: 11 - 11

12. Acenocoumarol/dabigatran etexilate

    Case report 10 October 2015 Pages: 12 - 12

13. Adalimumab/cyclophosphamide/methylprednisolone/prednisone

    Case report 10 October 2015 Pages: 13 - 13

14. Afatinib/cetuximab/panitumumab

    Case report 10 October 2015 Pages: 14 - 14

15. Alemtuzumab

    Case report 10 October 2015 Pages: 15 - 15

16. Alemtuzumab/antithymocyte globulin/tranexamic acid

    Case report 10 October 2015 Pages: 16 - 16

17. Allopurinol

    Case report 10 October 2015 Pages: 17 - 17

18. Alprazolam

    Case report 10 October 2015 Pages: 18 - 18

19. Amantadine

    Case report 10 October 2015 Pages: 19 - 19

20. Amiodarone

    Case report 10 October 2015 Pages: 20 - 20

21. Amiodarone/dexamethasone

    Case report 10 October 2015 Pages: 21 - 21

22. Amisulpride

    Case report 10 October 2015 Pages: 22 - 22

23. Amitriptyline/quetiapine/SSRIs

    Case report 10 October 2015 Pages: 23 - 23

24. Amphotericin B/amphotericin B liposomal

    Case report 10 October 2015 Pages: 24 - 24

25. Amphotericin-B

    Case report 10 October 2015 Pages: 25 - 25

26. Antineoplastic drugs

    Case report 10 October 2015 Pages: 26 - 26

27. Antineoplastics

    Case report 10 October 2015 Pages: 27 - 27

28. Antineoplastics

    Case report 10 October 2015 Pages: 28 - 28

29. Antineoplastics/hydrocortisone

    Case report 10 October 2015 Pages: 29 - 29

30. Antitubercular drugs

    Case report 10 October 2015 Pages: 30 - 30

31. Aripiprazole/clozapine

    Case report 10 October 2015 Pages: 31 - 31

32. Artemether/lumefantrine

    Case report 10 October 2015 Pages: 32 - 32

33. Aspirin/clopidogrel

    Case report 10 October 2015 Pages: 33 - 33

34. Atazanavir/raltegravir

    Case report 10 October 2015 Pages: 34 - 34

35. Atorvastatin

    Case report 10 October 2015 Pages: 35 - 35

36. Azathioprine

    Case report 10 October 2015 Pages: 36 - 36

37. Baclofen withdrawal

    Case report 10 October 2015 Pages: 37 - 37

38. BCG

    Case report 10 October 2015 Pages: 38 - 38

39. Betamethasone/doxorubicin liposomal

    Case report 10 October 2015 Pages: 39 - 39

40. Bevacizumab

    Case report 10 October 2015 Pages: 40 - 40

41. Bevacizumab/docetaxel/everolimus

    Case report 10 October 2015 Pages: 41 - 41

42. Bevacizumab/Irinotecan

    Case report 10 October 2015 Pages: 42 - 42

43. Bevacizumab/oxaliplatin/S-1

    Case report 10 October 2015 Pages: 43 - 43

44. Biperiden/diazepam/lorazepam/olanzapine/verapamil

    Case report 10 October 2015 Pages: 44 - 44

45. Bleomycin/dabrafenib

    Case report 10 October 2015 Pages: 45 - 45

46. Bortezomib

    Case report 10 October 2015 Pages: 46 - 46

47. Botulinum toxin A

    Case report 10 October 2015 Pages: 47 - 47

48. Bupropion/disulfiram interaction

    Case report 10 October 2015 Pages: 48 - 48

49. Calcium

    Case report 10 October 2015 Pages: 49 - 49

50. Canakinumab

    Case report 10 October 2015 Pages: 50 - 50